CSPC Innovation Pharmaceutical-A (300765 CH): Synthetic Expert Call Transcript (06 Oct 2026)
Structural Overcapacity in Caffeine Squeezes Margins: The global synthetic caffeine market—where CSPC Innovation holds a 60% to 70% global demand...
84 Views
Aequitas: CSPC Innovation Pharma A/H Listing - 1H26’s Performance Boosted by Licensing Deal
CSPC Innovation Pharmaceutical-A (300765 CH)Â CSPC Innovation Pharma aims to raise around US$500m in its H-share listing.
94 Views
Primer: CSPC Innovation Pharmaceutical-A (300765 CH) - Aug 2026
CSPC Innovation is undergoing a significant strategic pivot from a traditional bulk ingredients manufacturer, primarily caffeine, to an...
90 Views
Aequitas ECM Weekly (12 October 2026)-Wuxi Bio, CIG, CKD, Infroneer, JIO, ESWIN, Tinci, Transsion
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
100 Views
Pre-IPO CSPC Innovation Pharmaceutical (A/H Listing) - The Outlook Is Not Optimistic
​CSPC Innovation faces growth challenge with traditional business slowing down and new ventures needing stronger support. Valuation hinges on...
309 Views